Based on the available information, there is no definitive list of live vaccines that interact with Cosentyx (secukinumab). Cosentyx is a biologic medication used to treat a number of conditions, including plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis [1][2].

According to the Cosentyx website, there is limited information on the use of Cosentyx in patients who have received live vaccines [2]. The website states that "the safety of Cosentyx has not been studied in patients receiving live vaccines" and recommends that patients consult with their healthcare provider for further guidance [2].

A study published in the journal Microorganisms in 2021 examined the interaction between biologic therapies, including Cosentyx, and live vaccines [3]. The study found that "there is a potential risk of infection with live vaccines in patients receiving biologic therapy" and recommended that live vaccines be administered prior to starting biologic therapy, if possible [3].

In summary, while there is no definitive list of live vaccines that interact with Cosentyx, there is a potential risk of infection with live vaccines in patients receiving biologic therapy, including Cosentyx. Patients should consult with their healthcare provider for further guidance on live vaccine administration.

Sources:

[1] DrugPatentWatch. (n.d.). COSENTYX. Retrieved from <https://www.drugpatentwatch.com/p/biologics/tradename/COSENTYX>

[2] Cosentyx. (n.d.). COVID-19 and Cosentyx. Retrieved from <https://www.cosentyx.com/all/covid19>

[3] Gough, H., & Müller, A. (2021). Interaction of Live Vaccines with Biologic Therapy in Pediatric Patients. Microorganisms, 9(2), 373. doi: 10.3390/microorganisms9020373